Tate & Lyle, a well-known British ingredients firm, has been sold to US-based Ingredion for £2.7 billion, marking a significant shift in ownership as more UK-listed companies fall into foreign hands. The deal will see Tate & Lyle shareholders receiving 595p per share, along with an additional 20p in dividends. This acquisition comes amid challenges faced by Tate & Lyle, including a 10% drop in first-half profits and warnings about full-year earnings. The announcement of the deal led to a 45% increase in the company's shares, which had been under pressure due to rising costs and weak consumer demand. Jim Zallie, CEO of Ingredion, stated that the merger will enhance their ability to meet customer needs for healthier and affordable food products. This acquisition is part of a broader trend, with several UK firms, including laboratory testing company Intertek and insurance firm Beazley, also being acquired by foreign entities recently, highlighting ongoing concerns about the valuation of British companies in the market.